Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Olsson

Showing results (541-550 of 599) with videos related to

Pageof 60
Sort By:
Journal of Child Psychology and Psychiatry, and Allied Disciplines|May 7, 2024
Life course predictors of child emotional distress during the COVID-19 pandemic: Findings from a prospective intergenerational cohort studyPrimrose Letcher, Christopher J Greenwood, Jacqui A Macdonald, et al.
The European Respiratory Journal|June 18, 2026
Functional characterization of <b><i>KCNA5</i></b> gene variants linked to pulmonary arterial hypertensionRéka Csáki, Vasile Foris, Christina A Eichstaedt, et al.
International Journal of Cardiology|September 8, 2018
Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018Karen M Olsson, Michael Halank, Benjamin Egenlauf, et al.
Circulation|March 17, 2025
Correction to: Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 StudyMarius M Hoeper, Britta Oerke, Max Wissmüller, et al.
Frontiers in Psychiatry|June 17, 2021
Prevalence of Mental Disorders and Impact on Quality of Life in Patients With Pulmonary Arterial HypertensionKaren M Olsson, Tanja Meltendorf, Jan Fuge, et al.
Circulation|June 28, 2024
Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 StudyMarius M Hoeper, Britta Oerke, Max Wissmüller, et al.
Archives of Environmental Contamination and Toxicology|July 13, 2002
Global distribution of halogenated dimethyl bipyrroles in marine mammal blubberS Tittlemier, A Borrell, J Duffe, et al.
Nature Medicine|May 23, 2017
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drugHao Wu, Eduardo Esteve, Valentina Tremaroli, et al.
The European Respiratory Journal|October 20, 2018
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patientsMarion Delcroix, Gerd Staehler, Henning Gall, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 7, 2025
Add-on therapy with parenteral prostacyclin analogues in patients with pulmonary arterial hypertension: Insights from the COMPERA registryKhodr Tello, Marion Delcroix, Christine Pausch, et al.
Pageof 60

Showing results (541-550 of 599) with videos related to

Sort By:
Pageof 60
Journal of Child Psychology and Psychiatry, and Allied Disciplines|May 7, 2024
Life course predictors of child emotional distress during the COVID-19 pandemic: Findings from a prospective intergenerational cohort studyPrimrose Letcher, Christopher J Greenwood, Jacqui A Macdonald, et al.
The European Respiratory Journal|June 18, 2026
Functional characterization of <b><i>KCNA5</i></b> gene variants linked to pulmonary arterial hypertensionRéka Csáki, Vasile Foris, Christina A Eichstaedt, et al.
International Journal of Cardiology|September 8, 2018
Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018Karen M Olsson, Michael Halank, Benjamin Egenlauf, et al.
Circulation|March 17, 2025
Correction to: Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 StudyMarius M Hoeper, Britta Oerke, Max Wissmüller, et al.
Frontiers in Psychiatry|June 17, 2021
Prevalence of Mental Disorders and Impact on Quality of Life in Patients With Pulmonary Arterial HypertensionKaren M Olsson, Tanja Meltendorf, Jan Fuge, et al.
Circulation|June 28, 2024
Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 StudyMarius M Hoeper, Britta Oerke, Max Wissmüller, et al.
Archives of Environmental Contamination and Toxicology|July 13, 2002
Global distribution of halogenated dimethyl bipyrroles in marine mammal blubberS Tittlemier, A Borrell, J Duffe, et al.
Nature Medicine|May 23, 2017
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drugHao Wu, Eduardo Esteve, Valentina Tremaroli, et al.
The European Respiratory Journal|October 20, 2018
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patientsMarion Delcroix, Gerd Staehler, Henning Gall, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 7, 2025
Add-on therapy with parenteral prostacyclin analogues in patients with pulmonary arterial hypertension: Insights from the COMPERA registryKhodr Tello, Marion Delcroix, Christine Pausch, et al.
Pageof 60